Long-Term Opioid Therapy for Pain: What Is Known About Harms-and Still Not Known About Benefits

JAMA. 2025 Sep 23;334(12):1057-1058. doi: 10.1001/jama.2025.13225.
No abstract available

Plain language summary

This Viewpoint discusses recent US Food and Drug Administration data on opioid-related risks and harms; highlights ways in which understanding of these risks and harms remains incomplete; and calls for required postmarketing opioid studies and improved regulatory communications to ensure safer, more effective pain care.